MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $173,026,000 | -21.7% | 787,772 | -40.8% | 0.16% | -65.5% |
| Q3 2020 | $220,963,000 | -10.8% | 1,330,702 | -38.6% | 0.48% | -20.2% |
| Q2 2020 | $247,586,000 | +43.3% | 2,168,572 | -3.5% | 0.60% | +4.0% |
| Q1 2020 | $172,804,000 | -25.6% | 2,248,009 | +24.8% | 0.58% | -14.5% |
| Q4 2019 | $232,172,000 | +123.9% | 1,801,740 | +35.4% | 0.67% | +102.4% |
| Q3 2019 | $103,697,000 | -27.0% | 1,330,983 | -3.5% | 0.33% | -21.3% |
| Q2 2019 | $142,100,000 | – | 1,379,614 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |